Production and inspection method of propag hydrochloride for injection

By using raw materials such as acetaminophen and macroporous resin removal technology, combined with controlling cooling and crystal cultivation, the problems of low solubility and low catalytic efficiency in the preparation of propana hydrochloride for injection were solved, and high purity and stable propana hydrochloride were achieved. Patamo crystal production simplifies the detection process and improves the stability and storage of the product.

CN118908848AInactive Publication Date: 2024-11-08GUIZHOU RUNSHENG PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410925713.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-11
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing preparation methods for propana hydrochloride for injection have problems such as low solubility of acetone, difficulty in removing potassium chloride, and low catalytic efficiency, resulting in long reaction cycles, unstable product quality and easy moisture absorption, which is not conducive to storage.

Method used

Using raw materials such as acetaminophen, sodium lactate, ethanol, chloroacetyl chloride, glycerol, sodium carbonate, diethylamine and hydrogen chloride ethanol solutions, the preliminary removal of impurities and control cooling and crystal cultivation through macroporous resins, forming high-purity propatam hydrochloride crystals , dilute and dry with dilution solvent to ensure product stability.

Benefits of technology

The rapid production of high-purity propagatam hydrochloride crystals is achieved, which reduces the reaction time, improves the stability and storage of the product, simplifies the detection process, and ensures the high efficiency and quality of the product.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the technical field of drug synthesis, and discloses a production and inspection method of propamide hydrochloride for injection, which comprises the following raw materials: acetaminophen, sodium lactate, ethanol, chloroacetyl chloride, glycerol, sodium carbonate, diethylamine, a hydrogen chloride ethanol solution and a solvent for dilution. The preparation method comprises the following steps: mixing 90 parts by weight of acetaminophen, 200 parts by weight of sodium lactate and 490 parts by weight of ethanol, adjusting the pH value of the solution to 7.8, mixing and stirring for 15 minutes at 800rpm, dropwise adding 65 parts by weight of chloroacetyl chloride at 30 DEG C, after dropwise adding is finished within 10-20 minutes, treating by using macroporous resin, performing primary impurity removal, and performing vacuum drying to obtain a propacetamol hydrochloride crude product; the method comprises the following steps: adding an obtained propacetamol hydrochloride crude product into a diluted solution, heating to 55-95 DEG C, stirring until the propacetamol hydrochloride crude product is dissolved, filtering, cooling filtrate at a speed of 1-7 DEG C / h, cooling to 12-20 DEG C, and growing crystals in the solution at 12-20 DEG C, so that the high-purity propacetamol hydrochloride crystal is rapidly produced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of drug synthesis, in particular to a production method of propagulum hydrochloride for injection and a testing method thereof. Background Art

[0002] Propacetamol hydrochloride for injection is indicated for short-term treatment of moderate pain, especially postoperative pain, when intravenous administration is urgently needed to treat pain or high fever and other modes of administration are not suitable. It can also be used for short-term treatment of fever.

[0003] The current preparation method of propacetamol hydrochloride for injection uses acetone as a lysozyme, potassium carbonate as an acylation catalyst, and potassium iodide as an amination catalyst for reaction. This method has been able to obtain a high recovery rate and purity. However, this method has problems such as low solubility of acetone in potassium carbonate, difficulty in removing potassium chloride, and low catalytic efficiency, so the reaction and production cycle are long. If the reaction time is directly shortened, the yield and purity of the obtained product will be greatly affected. At the same time, in the prior art, the obtained product has unstable quality, is easy to absorb moisture, and is not conducive to storage.

[0004] Therefore, we proposed a production and testing method of propagate hydrochloride for injection. Summary of the invention

[0005] The present invention mainly solves the technical problems existing in the above-mentioned prior art and provides a production method of propagate hydrochloride for injection and a test method thereof.

[0006] In order to achieve the above object, the present invention adopts the following technical scheme: a production method of propazone hydrochloride for injection, comprising the following raw materials: acetaminophen, sodium lactate, ethanol, chloroacetyl chloride, glycerol, sodium carbonate, diethylamine, hydrogen chloride ethanol solution and a diluting solvent;

[0007] Take 90 parts by weight of acetaminophen, 200 parts by weight of sodium lactate and 490 parts by weight of ethanol, mix them, adjust the solution pH to 7.8, mix and stir (800 rpm) for 15 minutes, add 65 parts by weight of chloroacetyl chloride dropwise at 30°C, add 62 parts by weight of glycerol, 3 parts by weight of sodium carbonate and 90 parts by weight of diethylamine after the addition is completed within 10 to 20 minutes, add 62 parts by weight of glycerol, 3 parts by weight of sodium carbonate and 90 parts by weight of diethylamine, mix and stir (800 rpm) for 15 minutes, use macroporous resin treatment for preliminary impurity removal, and vacuum dry the resultant to obtain a crude product of propacetamol hydrochloride. The obtained crude product of propacetamol hydrochloride is added to a diluting solvent for cooling and crystal growth to obtain finished crystals.

[0008] Preferably, the macroporous resin treatment is used for preliminary impurity removal, and the product is dropwise added with hydrogen chloride ethanol solution under mixing and stirring (800 rpm) to pH 3.5 (completed within 3 to 5 minutes), and then filtered.

[0009] Preferably, the obtained crude propacetamol hydrochloride is added to water, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

[0010] Preferably, the obtained crude propacetamol hydrochloride is added to methanol, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

[0011] Preferably, the obtained crude propacetamol hydrochloride is added to ethanol, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

[0012] Preferably, the obtained crude propacetamol hydrochloride is added to acetone, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

[0013] A method for testing propagulum hydrochloride for injection, comprising visible spectrophotometric determination, chromatograph testing and weight loss detection.

[0014] Preferably, take 1.0g of the finished crystals, add 10ml of water to dissolve, the pH value should be 2.5-4.5. Clarity and color of the solution: take 1.75g ​​of this product, add 10ml of water to dissolve, the solution should be clear and colorless; if color is developed, measure it by UV-visible spectrophotometry, and measure the absorbance at a wavelength of 390nm, which shall not exceed 0.05.

[0015] Preferably, the determination method accurately measures the finished crystal solution and the reference solution, injects them into the liquid chromatograph respectively, and records the chromatogram to twice the retention time of the p-aminophenol peak. If there are impurity peaks in the chromatogram of the limit test solution, the p-aminophenol content shall not exceed 0.0025%, the acetaminophen content shall not exceed 0.02%, the peak area of ​​other single impurities multiplied by the relative correction factor of 1.6 shall not be greater than 3.2 times (0.1%) of the peak area of ​​acetaminophen in the reference solution, and the sum of the peak areas of other impurities multiplied by the relative correction factor of 1.6 shall not be greater than 6.4 times (0.2%) of the peak area of ​​acetaminophen in the reference solution, and shall be less than 0.01 times the peak area of ​​acetaminophen in the reference solution.

[0016] As a preferred embodiment, the test solution is about 0.5 g of the finished product crystal, accurately weighed, placed in an empty bottle, accurately added with water for 5 ml to dissolve, and sealed. The reference solution is respectively taken in appropriate amounts of methanol, ethanol, acetone and dichloromethane, accurately weighed, and quantitatively diluted with water to make a mixed solution containing 0.3 mg of methanol, 0.5 mg of ethanol, 0.5 ng of acetone and 60 μg of dichloromethane per 1 ml. Accurately measure 5 ml, place in an empty bottle at the top, seal, and the chromatographic conditions are a capillary chromatographic column with 6% cyanopropylphenyl-94% dimethylpolysiloxane (or similar polarity) as the stationary liquid, the initial temperature is 50°C, and the maintenance 7 minutes, heat to 200 ℃ at a rate of 25 ℃ per minute, maintain for 5 minutes, the injection port temperature is 150 ℃, the detector temperature is 250 ℃, the headspace bottle equilibrium temperature is 80 ℃, the equilibrium time is 30 minutes, the system suitability requirements of the reference solution chromatogram, the separation between the peaks of each component should meet the requirements, measure the finished crystal solution and the reference solution, respectively, headspace injection, record the chromatogram, the limit is calculated by the external standard method with the peak area, the residual amount of methanol, ethanol, acetone and dichloromethane should meet the requirements of drying loss take this product, at 105 ℃ dry to constant weight, the weight loss shall not exceed 0.5%.

[0017] Beneficial Effects

[0018] The present invention provides a production method and a testing method of propagulum hydrochloride for injection, which has the following beneficial effects:

[0019] (1) The production and inspection method of propacetamol hydrochloride for injection comprises the following steps: using a macroporous resin for preliminary impurity removal, dripping a hydrogen chloride ethanol solution to the product under mixing and stirring (800 rpm) to a pH of 3.5 (completed within 3 to 5 minutes), filtering, and vacuum drying the obtained product to obtain a crude propacetamol hydrochloride product; adding the obtained crude propacetamol hydrochloride product to a diluted solution, heating the solution to 55-95°C, stirring until dissolved, filtering, cooling the filtrate at a rate of 1-7°C / h to 12-20°C, growing crystals at 12-20°C, filtering, washing the filter cake, and vacuum drying at 50-55°C for 4 hours to obtain finished crystals, thereby achieving the effect of rapidly producing high-purity propacetamol hydrochloride crystals.

[0020] (2) The production and inspection method of propacetamol hydrochloride for injection comprises dissolving propacetamol hydrochloride in a polar solvent and forming a specific crystal form by controlling the cooling rate and crystal growing temperature. The obtained crystal form is not easy to absorb moisture, has stable quality, and is easy to store.

[0021] (3) The production and inspection method of this kind of propaqua hydrochloride for injection is as follows: take 1.0g of the finished product crystals, add 10ml of water to dissolve, and the pH value should be 2.5-4.5. The clarity and color of the solution: take 1.75g ​​of this product, add 10ml of water to dissolve, and the solution should be clear and colorless; if color is developed, measure it by ultraviolet visible spectrophotometry, and measure the absorbance at a wavelength of 390nm, which shall not exceed 0.05, thereby achieving the effect of quickly detecting the purity of the obtained product crystals.

[0022] (4) The production and inspection method of the propagulum hydrochloride for injection, the determination method is to accurately measure the finished product crystal solution and the reference solution, respectively inject them into the liquid chromatograph, record the chromatogram to twice the retention time of the p-aminophenol peak, and if there are impurity peaks in the chromatogram of the limit test solution, the p-aminophenol content shall not exceed 0.0025%, the acetaminophen content shall not exceed 0.02%, the peak area of ​​other single impurities multiplied by the relative correction factor of 1.6 shall not be greater than 3.2 times (0.1%) the peak area of ​​acetaminophen in the reference solution, the sum of the peak areas of other impurities multiplied by the relative correction factor of 1.6 shall not be greater than 6.4 times (0.2%) the peak area of ​​acetaminophen in the reference solution, and the chromatographic peak that is less than 0.01 times the peak area of ​​acetaminophen in the reference solution, and further quickly test whether the purity of the obtained product crystals is qualified. DETAILED DESCRIPTION

[0023] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0024] Embodiment 1: A method for producing propagulum hydrochloride for injection, comprising the following raw materials: acetaminophen, sodium lactate, ethanol, chloroacetyl chloride, glycerol, sodium carbonate, diethylamine, hydrogen chloride ethanol solution and a diluent solvent;

[0025] Take 90 parts by weight of acetaminophen, 200 parts by weight of sodium lactate and 490 parts by weight of ethanol, mix them, adjust the solution pH to 7.8, mix and stir (800 rpm) for 15 minutes, add 65 parts by weight of chloroacetyl chloride dropwise at 30°C, add 62 parts by weight of glycerol, 3 parts by weight of sodium carbonate and 90 parts by weight of diethylamine after the addition is completed within 10 to 20 minutes, and mix and stir (800 rpm) for 15 minutes;

[0026] The product was treated with a macroporous resin for preliminary impurity removal, and a hydrogen chloride ethanol solution was added dropwise to the product under mixing and stirring (800 rpm) until the pH value was 3.5 (completed within 3 to 5 minutes), and then filtered, and the obtained product was vacuum dried to obtain a crude product of propacetamol hydrochloride;

[0027] The obtained crude propacetamol hydrochloride is added into water, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

[0028] Example 2: A method for producing propapa hydrochloride for injection, comprising the following raw materials: acetaminophen, sodium lactate, ethanol, chloroacetyl chloride, glycerol, sodium carbonate, diethylamine, hydrogen chloride ethanol solution and a diluent solvent;

[0029] Take 90 parts by weight of acetaminophen, 200 parts by weight of sodium lactate and 490 parts by weight of ethanol, mix them, adjust the solution pH to 7.8, mix and stir (800 rpm) for 15 minutes, add 65 parts by weight of chloroacetyl chloride dropwise at 30°C, add 62 parts by weight of glycerol, 3 parts by weight of sodium carbonate and 90 parts by weight of diethylamine after the addition is completed within 10 to 20 minutes, and mix and stir (800 rpm) for 15 minutes;

[0030] The product was treated with a macroporous resin for preliminary impurity removal, and a hydrogen chloride ethanol solution was added dropwise to the product under mixing and stirring (800 rpm) until the pH value was 3.5 (completed within 3 to 5 minutes), and then filtered, and the obtained product was vacuum dried to obtain a crude product of propacetamol hydrochloride;

[0031] The obtained crude propacetamol hydrochloride is added to methanol, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

[0032] Example 3: A method for producing propapa hydrochloride for injection, comprising the following raw materials: acetaminophen, sodium lactate, ethanol, chloroacetyl chloride, glycerol, sodium carbonate, diethylamine, hydrogen chloride ethanol solution and a diluent solvent;

[0033] Take 90 parts by weight of acetaminophen, 200 parts by weight of sodium lactate and 490 parts by weight of ethanol, mix them, adjust the solution pH to 7.8, mix and stir (800 rpm) for 15 minutes, add 65 parts by weight of chloroacetyl chloride dropwise at 30°C, add 62 parts by weight of glycerol, 3 parts by weight of sodium carbonate and 90 parts by weight of diethylamine after the addition is completed within 10 to 20 minutes, and mix and stir (800 rpm) for 15 minutes;

[0034] The product was treated with a macroporous resin for preliminary impurity removal, and a hydrogen chloride ethanol solution was added dropwise to the product under mixing and stirring (800 rpm) until the pH value was 3.5 (completed within 3 to 5 minutes), and then filtered, and the obtained product was vacuum dried to obtain a crude product of propacetamol hydrochloride;

[0035] The obtained crude propacetamol hydrochloride is added to ethanol, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

[0036] Example 4: A method for producing propapa hydrochloride for injection, comprising the following raw materials: acetaminophen, sodium lactate, ethanol, chloroacetyl chloride, glycerol, sodium carbonate, diethylamine, hydrogen chloride ethanol solution and a diluent solvent;

[0037] Take 90 parts by weight of acetaminophen, 200 parts by weight of sodium lactate and 490 parts by weight of ethanol, mix them, adjust the solution pH to 7.8, mix and stir (800 rpm) for 15 minutes, add 65 parts by weight of chloroacetyl chloride dropwise at 30°C, add 62 parts by weight of glycerol, 3 parts by weight of sodium carbonate and 90 parts by weight of diethylamine after the addition is completed within 10 to 20 minutes, and mix and stir (800 rpm) for 15 minutes;

[0038] The product was treated with a macroporous resin for preliminary impurity removal, and a hydrogen chloride ethanol solution was added dropwise to the product under mixing and stirring (800 rpm) until the pH value was 3.5 (completed within 3 to 5 minutes), and then filtered, and the obtained product was vacuum dried to obtain a crude product of propacetamol hydrochloride;

[0039] The obtained crude propacetamol hydrochloride is added to acetone, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

[0040] A method for testing propagulum hydrochloride for injection: comprising the following methods:

[0041] Method 1: Take 1.0g of the finished crystals, add 10ml of water to dissolve, the pH value should be 2.5-4.5. Clarity and color of the solution: Take 1.75g ​​of this product, add 10ml of water to dissolve, the solution should be clear and colorless; if color is developed, measure it by UV-visible spectrophotometry, and measure the absorbance at a wavelength of 390nm, which shall not exceed 0.05.

[0042] Method 2. Determination method: Accurately measure the finished crystal solution and the reference solution, inject them into the liquid chromatograph respectively, and record the chromatogram to twice the retention time of the p-aminophenol peak. If there are impurity peaks in the chromatogram of the limit test solution, calculate the peak area by the external standard method. The p-aminophenol content shall not exceed 0.0025%, the acetaminophen content shall not exceed 0.02%, the peak area of ​​other single impurities multiplied by the relative correction factor of 1.6 shall not be greater than 3.2 times (0.1%) of the peak area of ​​acetaminophen in the reference solution, and the sum of the peak areas of other impurities multiplied by the relative correction factor of 1.6 shall not be greater than 6.4 times (0.2%) of the peak area of ​​acetaminophen in the reference solution. The chromatographic peak that is less than 0.01 times the peak area of ​​acetaminophen in the reference solution (peak area multiplied by the relative correction factor of 1.6) shall be ignored for residual solvents according to the residual solvent determination method.

[0043] Method 3: Test solution: Take about 0.5 g of the finished product crystals, accurately weigh them, place them in an empty bottle, accurately add 5 ml of water to dissolve them, and seal them. For the reference solution, take appropriate amounts of methanol, ethanol, acetone, and dichloromethane, accurately weigh them, and quantitatively dilute them with water to make a mixed solution containing 0.3 mg of methanol, 0.5 mg of ethanol, 0.5 ng of acetone, and 60 μg of dichloromethane per ml. Accurately measure 5 ml, place them in an empty bottle, and seal them. Chromatographic conditions: use a capillary column with 6% cyanopropylphenyl-94% dimethylpolysiloxane (or similar polarity) as the stationary phase, the starting temperature is 50°C, and the temperature is maintained at 7 minutes, heat to 200℃ at a rate of 25℃ per minute, maintain for 5 minutes, the injection port temperature is 150℃, the detector temperature is 250℃, the headspace bottle equilibrium temperature is 80℃, the equilibrium time is 30 minutes, and the system suitability requires that the separation between the peaks of the reference solution chromatogram should meet the requirements, measure the finished crystal solution and the reference solution, respectively, headspace injection, record the chromatogram, the limit is calculated by the external standard method with the peak area, the residual amounts of methanol, ethanol, acetone and dichloromethane should meet the requirements. Loss on drying: Take this product and dry it at 105℃ to constant weight. The weight loss shall not exceed 0.5%.

[0044] The above shows and describes the basic principles and main features of the present invention and the advantages of the present invention. It should be understood by those skilled in the art that the present invention is not limited to the above embodiments. The above embodiments and descriptions are only for explaining the principles of the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, which fall within the scope of the present invention to be protected. The scope of protection of the present invention is defined by the attached claims and their equivalents.

[0045] Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making any creative work shall fall within the scope of protection of the present invention.

[0046] In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.

[0047] In the present invention, unless otherwise clearly specified and limited, the terms "installed", "connected", "connected", "fixed" and the like should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be directly connected or indirectly connected through an intermediate medium, it can be the internal connection of two elements or the interaction relationship between two elements. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.

[0048] In the present invention, unless otherwise clearly specified and limited, a first feature being "above" or "below" a second feature may include that the first and second features are in direct contact, or may include that the first and second features are not in direct contact but are in contact through another feature between them. Moreover, a first feature being "above", "above" and "above" a second feature includes that the first feature is directly above and obliquely above the second feature, or simply indicates that the first feature is higher in level than the second feature. A first feature being "below", "below" and "below" a second feature includes that the first feature is directly below and obliquely below the second feature, or simply indicates that the first feature is lower in level than the second feature.

Claims

1. A method for producing propagulum hydrochloride for injection, characterized in that: The raw materials include acetaminophen, sodium lactate, ethanol, chloroacetyl chloride, glycerol, sodium carbonate, diethylamine, ethanol solution of hydrogen chloride and diluent solvent; Take 90 parts by weight of acetaminophen, 200 parts by weight of sodium lactate and 490 parts by weight of ethanol, mix them, adjust the solution pH to 7.8, mix and stir (800 rpm) for 15 minutes, add 65 parts by weight of chloroacetyl chloride dropwise at 30°C, add 62 parts by weight of glycerol, 3 parts by weight of sodium carbonate and 90 parts by weight of diethylamine after the addition is completed within 10 to 20 minutes, add 62 parts by weight of glycerol, 3 parts by weight of sodium carbonate and 90 parts by weight of diethylamine, mix and stir (800 rpm) for 15 minutes, use macroporous resin treatment for preliminary impurity removal, and vacuum dry the resultant to obtain a crude product of propacetamol hydrochloride. The obtained crude product of propacetamol hydrochloride is added to a diluting solvent for cooling and crystal growth to obtain finished crystals.

2. The method for producing propagulum hydrochloride for injection according to claim 1, characterized in that: The macroporous resin treatment is used for preliminary impurity removal, and the product is dropwise added with hydrogen chloride ethanol solution under mixing and stirring (800 rpm) to pH 3.5 (completed within 3 to 5 minutes), and then filtered.

3. The method for producing propagulum hydrochloride for injection according to claim 1, characterized in that: The obtained crude propacetamol hydrochloride is added into water, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

4. The method for producing propagulum hydrochloride for injection according to claim 1, characterized in that: The obtained crude propacetamol hydrochloride is added to methanol, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

5. The method for producing propagulum hydrochloride for injection according to claim 1, characterized in that: The obtained crude propacetamol hydrochloride is added to ethanol, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

6. The method for producing propagulum hydrochloride for injection according to claim 1, characterized in that: The obtained crude propacetamol hydrochloride is added to acetone, heated to 55-95°C, stirred until dissolved, filtered, and the filtrate is cooled at a rate of 1-7°C / h to 12-20°C, and crystals are grown at 12-20°C in the solution, filtered, the filter cake is washed, and vacuum dried at 50-55°C for 4h to obtain finished crystals.

7. A method for testing propagulum hydrochloride for injection, characterized in that: Includes visible spectrophotometry, chromatograph testing and loss-in-weight testing.

8. The method for testing propagulum hydrochloride for injection according to claim 7, characterized in that: Take 1.0g of the finished crystals, add 10ml of water to dissolve, the pH value should be 2.5-4.

5. Clarity and color of the solution: Take 1.75g ​​of this product, add 10ml of water to dissolve, the solution should be clear and colorless; if color is developed, measure it by UV-visible spectrophotometry, and measure the absorbance at a wavelength of 390nm, which shall not exceed 0.

05.

9. The method for testing propagulum hydrochloride for injection according to claim 7, characterized in that: Determination method: Accurately measure the finished crystal solution and the reference solution, inject them into the liquid chromatograph respectively, and record the chromatogram to twice the retention time of the p-aminophenol peak. If there are impurity peaks in the chromatogram of the limit test solution, calculate the peak area by the external standard method. The p-aminophenol content shall not exceed 0.0025%, the acetaminophen content shall not exceed 0.02%, and the peak area of ​​other single impurities multiplied by the relative correction factor of 1.6 shall not be greater than 3.2 times (0.1%) of the peak area of ​​acetaminophen in the reference solution. The sum of the peak areas of other impurities multiplied by the relative correction factor of 1.6 shall not be greater than 6.4 times (0.2%) of the peak area of ​​acetaminophen in the reference solution, and shall be less than 0.01 times the peak area of ​​acetaminophen in the reference solution.

10. The method for testing propagulum hydrochloride for injection according to claim 7, characterized in that: For the test solution, take about 0.5g of the finished product crystals, accurately weigh, place in an empty bottle, accurately add 5ml of water to dissolve, and seal. For the reference solution, take appropriate amounts of methanol, ethanol, acetone and dichloromethane, accurately weigh, and quantitatively dilute with water to make a mixed solution containing 0.3mg of methanol, 0.5mg of ethanol, 0.5ng of acetone and 60μg of dichloromethane per 1ml. Accurately measure 5ml, place in an empty bottle, seal. Chromatographic conditions: use a capillary column with 6% cyanopropylphenyl-94% dimethylpolysiloxane (or similar polarity) as the stationary phase, the starting temperature is 50℃, and the temperature is maintained for 7 minutes. , heat up to 200℃ at a rate of 25℃ per minute, maintain for 5 minutes, the injection port temperature is 150℃, the detector temperature is 250℃, the headspace bottle equilibrium temperature is 80℃, and the equilibrium time is 30 minutes. The system suitability requires that the separation between the peaks of each component in the chromatogram of the reference solution should meet the requirements. The finished crystal solution and the reference solution are measured by headspace injection respectively, and the chromatograms are recorded. The limit is calculated by the external standard method with the peak area. The residual amounts of methanol, ethanol, acetone and dichloromethane should meet the requirements. Loss on drying: Take this product and dry it at 105℃ to constant weight. The weight loss shall not exceed 0.5%.